Financials

  • Market Capitalization 22 M
  • Employee 115
  • Founded 1998
  • CEO N/A
  • Website www.celularity.com
  • Headquarter Delaware, United States
  • FIGI BBG00P2RTT34
  • Industry Biotecnologia
Ricavi totali
Utile netto
Utile base per azione (EPS base)
Debito totale
Liquidità libera
Disponibilità liquide e mezzi equivalenti
Rapporto prezzo/utili
-0.31
Rapporto prezzo/fatturato
1.07

Related tickers

#NomePrezzo24h %7d %1M %1Y %Valore di MercatoUltimi 7 Giorni
4591
VYNE
VYNE Therapeutics Inc. - Common Stock
0.65 USD-1.52%0.00%0.00%-50.76%21.68 M USD
4592
KZIA
Kazia Therapeutics Limited - American Depositary Shares
13.67 USD+0.59%+3.95%-6.11%+133.68%22.13 M USD
4604
CLRB
Cellectar Biosciences, Inc. - Common Stock
2.69 USD+2.28%+0.37%+16.96%-14.33%21.50 M USD
4606
TVGN
Tevogen Bio Holdings Inc. - Common Stock
5.17 USD+3.40%-12.52%-50.38%+310.32%21.65 M USD

Notizie